CYRX
Cryoport, Inc.
+0.39 (+2.36%)16.90USD112K成交股數856M市值–本益比(近四季)4.6股價營收比+7.7%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 49.0M+19% | 47.8M+15% | 44.2M+15% | 45.5M+14% | 41.0M+10% | 41.5M-26% | 38.3M-33% | 39.7M-37% | 37.3M | 56.2M | 57.0M | 62.8M |
| 營業成本 | 26.1M | 25.9M | 22.9M | 24.1M | 22.4M | 22.0M | 20.9M | 22.0M | 22.2M | 31.9M | 32.3M | 35.7M |
| 毛利 | 22.8M+22% | 21.9M+12% | 21.3M+22% | 21.4M+21% | 18.6M+24% | 19.5M-20% | 17.4M-30% | 17.7M-35% | 15.1M | 24.3M | 24.7M | 27.1M |
| 毛利率 | 46.6% | 45.8% | 48.2% | 47.0% | 45.4% | 47.0% | 45.5% | 44.5% | 40.4% | 43.2% | 43.4% | 43.1% |
| 研發費用 | 4.9M | 3.9M | 4.5M | 4.1M | 3.9M | 4.2M | 4.2M | 4.6M | 4.8M | 5.2M | 4.3M | 3.9M |
| 銷售管理費用 | 28.0M | 27.6M | 26.7M | 26.9M | 21.9M | 28.1M | 26.7M | 27.2M | 27.8M | 36.0M | 38.8M | 33.2M |
| 營業利益 | −10.0M+40% | −9.6M-25% | −9.9M-26% | −9.6M-88% | −7.2M-59% | −12.7M-25% | −13.4M-27% | −78.0M+677% | −17.5M | −16.9M | −18.3M | −10.0M |
| 營業利益率 | -20.5% | -20.1% | -22.5% | -21.2% | -17.5% | -30.7% | -34.9% | -196.5% | -46.9% | -30.1% | -32.1% | -16.0% |
| 稅後淨利 | −8.3M-31% | −10.5M-44% | −6.9M-962% | 109M-240% | −12.0M-37% | −18.7M+41% | 805K-104% | −78.0M+1299% | −18.9M | −13.3M | −18.4M | −5.6M |
| 淨利率 | -16.9% | -22.1% | -15.7% | 239.5% | -29.2% | -45.1% | 2.1% | -196.4% | -50.7% | -23.6% | -32.2% | -8.9% |
| 稀釋 EPS | -0.20-29% | -0.25-40% | -0.18+800% | 2.13-231% | -0.28-35% | -0.42+35% | -0.02-95% | -1.62+913% | -0.43 | -0.31 | -0.42 | -0.16 |
| 稀釋股數 | 50.4M | 49.9M | 50.1M | 50.3M | 49.9M | 49.3M | 49.4M | 49.3M | 49.0M | 48.9M | 48.7M | 48.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 269M | 273M | 256M | 243M | 36.1M | 34.1M | 31.4M | 34.2M | 39.3M | 59.5M | 67.3M | 38.5M |
| 應收帳款 | 36.5M | 39.0M | 34.9M | 33.4M | 28.4M | 25.3M | 43.5M | 40.2M | 41.3M | 42.6M | 43.1M | 45.6M |
| 存貨 | 21.5M | 21.8M | 23.3M | 23.0M | 23.3M | 21.5M | 23.6M | 23.6M | 25.0M | 29.1M | 28.8M | 26.5M |
| 總資產 | 756M | 764M | 774M | 774M | 700M | 703M | 702M | 852M | 943M | 1.0B | 1.0B | 1.0B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 266M | 269M | 261M | 259M | 301M | 302M | 283M | 452M | 471M | 463M | 486M | 488M |
| 股東權益 | 491M | 495M | 513M | 519M | 399M | 402M | 419M | 400M | 472M | 538M | 544M | 561M |
| 負債比 | 35.1% | 35.2% | 33.7% | 33.4% | 43.0% | 42.9% | 40.4% | 53.1% | 49.9% | 46.3% | 47.2% | 46.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 3.7M | – | – | −4.3M+33% | – | – | – | −3.3M | – | – | 2.8M |
| 資本支出 | – | 10.0M | – | – | 3.2M | – | – | – | 4.0M | – | – | 9.6M |
| 自由現金流 | – | −6.2M | – | – | −7.5M+3% | – | – | – | −7.3M | – | – | −6.8M |
| 折舊攤銷 | – | 6.4M | – | – | 7.6M | – | – | – | 7.5M | – | – | 6.4M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -13.1% | – | – | -18.3% | – | – | – | -19.5% | – | – | -10.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 176M
| 美洲 | 131M | 74.5% | +15.6% |
|---|---|---|---|
| 歐洲中東非洲 | 25.1M | 14.3% | -7.0% |
| 亞太 | 19.8M | 11.2% | +22.1% |
主要客戶2025 年度 · 44.9M
| Foreign Customers | 44.9M | 100.0% | +3.9% |
|---|
產品／服務2025 年度 · 176M
| 產品 | 79.7M | 45.2% | +6.6% |
|---|---|---|---|
| Biologistics Solutions | 78.1M | 44.4% | +16.6% |
| Biostorage Bioservices | 18.4M | 10.4% | +22.2% |
| 服務 小計 | 96.5M | 54.8% | +17.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 176M | +12.4% | 78.3M | 44.4% | 1.40 | −25.0M |
| FY2024 | 157M | -7.1% | −115M | -73.2% | -2.49 | −33.6M |
| FY2023 | 169M | -28.9% | −99.6M | -59.0% | -2.21 | −39.5M |
| FY2022 | 237M | +6.6% | −37.3M | -15.7% | -0.93 | −24.0M |
| FY2021 | 223M | +182.9% | −276M | -123.8% | -6.18 | −15.8M |
| FY2020 | 78.7M | +131.9% | −32.7M | -41.5% | -1.94 | −23.8M |
| FY2019 | 33.9M | +72.9% | −18.3M | -54.0% | -0.55 | −6.7M |
| FY2018 | 19.6M | – | −9.6M | -48.7% | -0.34 | −6.3M |